PRC
IRWD icon

Pearl River Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pearl River Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,537
Closed -$193K – 609
2019
Q4 		$193K Buy
+14,537
New +$160K 0.07% 483
2019
Q1 		– Sell
-2,572
Closed -$22K – 557
2018
Q4 		$22K Buy
+2,572
New +$29.5K 0.1% 262

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Pearl River Capital's IRWD Position: Q1 2020 in Review

Pearl River Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2020, closing a stake of 14,537 shares — an estimated $193K sold.

Pearl River Capital first reported a position in IRWD in Q4 2018 and held it in 2 quarters. The position peaked at $193K in Q4 2019. 193 funds tracked by Wall St. Rank hold IRWD as of Q1 2020.

  • Pearl River Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Pearl River Capital sold 14,537 Ironwood Pharmaceuticals shares in Q1 2020, an estimated $193K.
  • Pearl River Capital first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Pearl River Capital's Ironwood Pharmaceuticals position peaked at $193K in Q4 2019.
  • 193 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2020.

Based on Pearl River Capital's 13F filing for Q1 2020, filed 6 May 2020.